These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28534080)

  • 1. Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
    Lorimer PD; Motz BM; Kirks RC; Boselli DM; Walsh KK; Prabhu RS; Hill JS; Salo JC
    Ann Surg Oncol; 2017 Aug; 24(8):2095-2103. PubMed ID: 28534080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Al-Sukhni E; Attwood K; Mattson DM; Gabriel E; Nurkin SJ
    Ann Surg Oncol; 2016 Apr; 23(4):1177-86. PubMed ID: 26668083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation.
    Probst CP; Becerra AZ; Aquina CT; Tejani MA; Wexner SD; Garcia-Aguilar J; Remzi FH; Dietz DW; Monson JR; Fleming FJ;
    J Am Coll Surg; 2015 Aug; 221(2):430-40. PubMed ID: 26206642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-course Versus Long-course Neoadjuvant Therapy for Non-metastatic Rectal Cancer: Patterns of Care and Outcomes From the National Cancer Database.
    Dutta SW; Alonso CE; Jones TC; Waddle MR; Janowski EM; Trifiletti DM
    Clin Colorectal Cancer; 2018 Dec; 17(4):297-306. PubMed ID: 30146228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
    Huntington CR; Boselli D; Symanowski J; Hill JS; Crimaldi A; Salo JC
    Ann Surg Oncol; 2016 Mar; 23(3):877-87. PubMed ID: 26514119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
    Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
    Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
    Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
    Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single institution's long-term follow-up of patients with pathological complete response in locally advanced rectal adenocarcinoma following neoadjuvant chemoradiotherapy.
    Runau F; Collins A; Fenech GA; Ford E; Dimitriou N; Chaudhri S; Yeung JM
    Int J Colorectal Dis; 2017 Mar; 32(3):341-348. PubMed ID: 27885480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Pathological Response After Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer and Its Relationship to the Degree of T3 Mesorectal Invasion.
    Wilkins S; Haydon A; Porter I; Oliva K; Staples M; Carne P; McMurrick P; Bell S
    Dis Colon Rectum; 2016 May; 59(5):361-8. PubMed ID: 27050597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NPTX2 is associated with neoadjuvant therapy response in rectal cancer.
    Karagkounis G; Thai L; DeVecchio J; Gantt GA; Duraes L; Pai RK; Kalady MF
    J Surg Res; 2016 May; 202(1):112-7. PubMed ID: 27083956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
    Geva R; Davidovics H; Soyfer S; Pelles-Avraham S; Klausner JM; Inbar M; Tulchinsky H
    Colorectal Dis; 2017 Mar; 19(3):237-242. PubMed ID: 27474791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
    Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEOADJUVANT THERAPY AND SURGERY FOR RECTAL CANCER. Comparative study between partial and complete pathological response.
    Andrade VA; Coy CS; Leal RF; Fagundes JJ; Martinez CA; Ayrizono Mde L
    Arq Gastroenterol; 2016; 53(3):163-8. PubMed ID: 27438421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
    de Campos-Lobato LF; Dietz DW; Stocchi L; Vogel JD; Lavery IC; Goldblum JR; Skacel M; Pelley RJ; Kalady MF
    Colorectal Dis; 2012 Jan; 14(1):62-7. PubMed ID: 21176057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.